SINGAPORE (May 15): Net profit of catalist-listed pharmaceutical distributor Hyphens Pharma soared 48.6% to $2.1 million in 1Q20 ended March, from the $1.4 million logged a year ago.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.

Bonus:

  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply

Subscribe